Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Peeper

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Nature|August 5, 2005
BRAFE600-associated senescence-like cell cycle arrest of human naeviChrysiis Michaloglou, Liesbeth C W Vredeveld, Maria S Soengas, et al.
Endocrine-Related Cancer|September 23, 2011
Evidence of oncogene-induced senescence in thyroid carcinogenesisMaria Grazia Vizioli, Patricia A Possik, Eva Tarantino, et al.
Genes & Development|May 3, 2012
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesisLiesbeth C W Vredeveld, Patricia A Possik, Marjon A Smit, et al.
Melanoma Research|December 22, 2022
MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistanceDisha Rao, Ruben Lacroix, Alex Rooker, et al.
Molecular Cell|September 25, 2021
Oncogene-dependent sloppiness in mRNA translationJulien Champagne, Abhijeet Pataskar, Naomi Blommaert, et al.
BMC Cancer|September 17, 2017
Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter studyBernies van der Hiel, John B A G Haanen, Marcel P M Stokkel, et al.
Molecular Systems Biology|March 7, 2018
Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitorsAlireza Azimi, Stefano Caramuta, Brinton Seashore-Ludlow, et al.
Nucleic Acids Research|November 26, 2024
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancerAdva Kochavi, Remco Nagel, Pierre-Rene Körner, et al.
Oncoimmunology|December 5, 2022
<i>SERPINB9</i> is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade responseSofía Ibáñez-Molero, Alex van Vliet, Joanna Pozniak, et al.
Pigment Cell & Melanoma Research|March 3, 2015
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCKCelia J Vogel, Marjon A Smit, Gianluca Maddalo, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Nature|August 5, 2005
BRAFE600-associated senescence-like cell cycle arrest of human naeviChrysiis Michaloglou, Liesbeth C W Vredeveld, Maria S Soengas, et al.
Endocrine-Related Cancer|September 23, 2011
Evidence of oncogene-induced senescence in thyroid carcinogenesisMaria Grazia Vizioli, Patricia A Possik, Eva Tarantino, et al.
Genes & Development|May 3, 2012
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesisLiesbeth C W Vredeveld, Patricia A Possik, Marjon A Smit, et al.
Melanoma Research|December 22, 2022
MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistanceDisha Rao, Ruben Lacroix, Alex Rooker, et al.
Molecular Cell|September 25, 2021
Oncogene-dependent sloppiness in mRNA translationJulien Champagne, Abhijeet Pataskar, Naomi Blommaert, et al.
BMC Cancer|September 17, 2017
Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter studyBernies van der Hiel, John B A G Haanen, Marcel P M Stokkel, et al.
Molecular Systems Biology|March 7, 2018
Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitorsAlireza Azimi, Stefano Caramuta, Brinton Seashore-Ludlow, et al.
Nucleic Acids Research|November 26, 2024
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancerAdva Kochavi, Remco Nagel, Pierre-Rene Körner, et al.
Oncoimmunology|December 5, 2022
<i>SERPINB9</i> is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade responseSofía Ibáñez-Molero, Alex van Vliet, Joanna Pozniak, et al.
Pigment Cell & Melanoma Research|March 3, 2015
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCKCelia J Vogel, Marjon A Smit, Gianluca Maddalo, et al.
Pageof 12